{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:11:30Z","timestamp":1777126290142,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011903","name":"Gedeon Richter Talentum Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejps.2018.12.012","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T17:57:58Z","timestamp":1544723878000},"page":"232-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability"],"prefix":"10.1016","volume":"128","author":[{"given":"Gerg\u0151","family":"Darg\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vincze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huba J.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-1760","authenticated-orcid":false,"given":"Gy\u00f6rgy T.","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.12.012_bb0005","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2018.12.012_bb0010","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s13346-015-0275-6","article-title":"In vitro and ex vivo corneal penetration and absorption models","volume":"6","author":"Agarwal","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2018.12.012_bb0015","series-title":"Ophthalmic Drug Delivery Systems","first-page":"356","article-title":"The noncorneal route in ocular drug delivery","author":"Ahmed","year":"2003"},{"key":"10.1016\/j.ejps.2018.12.012_bb0020","series-title":"Absorption and Drug Development","first-page":"319","article-title":"Permeability-PAMPA","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.ejps.2018.12.012_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejps.2018.12.012_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.12.012_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2015.06.019","article-title":"In vitro dissolution\u2013permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using \u03bcFlux\u2122","volume":"491","author":"Borb\u00e1s","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.12.012_bb0040","first-page":"67","article-title":"Corneal permeability of adrenergic agents potentially useful in glaucoma","volume":"38","author":"Chiang","year":"1986","journal-title":"J. Taiwan Pharm. Assoc."},{"key":"10.1016\/j.ejps.2018.12.012_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/17425255.2011.570334","article-title":"Corneal cell culture models: a tool to study corneal drug absorption","volume":"7","author":"Dey","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2018.12.012_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jps.2600740210","article-title":"Topical carbonic anhydrase inhibitors III: optimization model for corneal penetration of ethoxzolamide analogues","volume":"74","author":"Eller","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0055","series-title":"Human Physiology","first-page":"266","article-title":"Sensory physiology","author":"Fox","year":"2016"},{"key":"10.1016\/j.ejps.2018.12.012_bb0060","author":"GraphPad Software"},{"key":"10.1016\/j.ejps.2018.12.012_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jps.2600770103","article-title":"Mechanisms of corneal drug penetration I: in vivo and in vitro kinetics","volume":"77","author":"Grass","year":"1988","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cem.1320","article-title":"Sum of ranking differences for method discrimination and its validation: comparison of ranks with random numbers","volume":"25","author":"H\u00e9berger","year":"2011","journal-title":"J. Chemom."},{"key":"10.1016\/j.ejps.2018.12.012_bb0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1254\/jjp.34.429","article-title":"Studies on rabbit corneal permeability of local anesthetics (I)","volume":"34","author":"Igarashi","year":"1984","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejps.2018.12.012_bb0080","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1007\/s11095-010-0132-8","article-title":"Prediction of the corneal permeability of drug-like compounds","volume":"27","author":"Kidron","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.12.012_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1389200033489488","article-title":"Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond","volume":"4","author":"Koevary","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2018.12.012_bb0090","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/jps.2600721109","article-title":"Corneal penetration behavior of \u03b2-blocking agents II: assessment of barrier contributions","volume":"72","author":"Lach","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9394(86)90771-3","article-title":"Drop size of commercial glaucoma medications","author":"Lederer","year":"1986","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.ejps.2018.12.012_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-3659(96)01503-9","article-title":"Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea","volume":"44","author":"Muchtar","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.12.012_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2015.08.019","article-title":"Tuning the predictive capacity of the PAMPA-BBB model","volume":"79","author":"M\u00fcller","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0110","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/IAI.64.5.1819-1825.1996","article-title":"Pathogenesis of corneal infection: binding of Pseudomonas aeruginosa to specific phospholipids","volume":"64","author":"Panjwani","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2018.12.012_bb0115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0120","unstructured":"Rusinko, A., Hellberg, M.R., May, J.A., Owen, G.R., 2008. Use of MDCK cell line to predict corneal penetration of drugs. US 20080138849 A1."},{"key":"10.1016\/j.ejps.2018.12.012_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-199018040-00001","article-title":"Ocular drug delivery. Pharmacokinetic considerations","volume":"18","author":"Schoenwald","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.12.012_bb0130","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600721108","article-title":"Corneal penetration behavior of \u03b2-blocking agents I: physicochemical factors","volume":"72","author":"Schoenwald","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0135","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jps.2600670614","article-title":"Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients","volume":"67","author":"Schoenwald","year":"1978","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejps.2012.01.011","article-title":"Skin-PAMPA: a new method for fast prediction of skin penetration","volume":"45","author":"Sink\u00f3","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0145","series-title":"Ophthalmic Drug Delivery Systems","first-page":"13","article-title":"Membrane transport processes in the eye","author":"Sunkara","year":"2003"},{"key":"10.1016\/j.ejps.2018.12.012_bb0150","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/108076803322660468","article-title":"Corneal and scleral permeability of quinolones\u2014a pharmacokinetics study","volume":"19","author":"Tai","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.12.012_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jps.2600830120","article-title":"Effects of four penetration enhancers on corneal permeability of drugs in vitro","volume":"83","author":"Tang-Liu","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.12.012_bb0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02713689109001766","article-title":"Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration","volume":"10","author":"Wang","year":"1991","journal-title":"Curr. Eye Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718305475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718305475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T15:03:55Z","timestamp":1605625435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718305475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":32,"alternative-id":["S0928098718305475"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.12.012","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}